Indirect costs assessment and intangible costs description of rheumatoid arthritis patients with biological therapy in Morocco: ECORAM Study.

Autor: Zarrik H; Research Team of Pharmacoeconomics and Pharmacoepidemiology, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco., Hassani AC; Laboratory of analytical chemistry, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco., Rkain H; Department of Rheumatology B, El Ayachi Hospital, Ibn Sina University Hospital, Salé, Morocco.; Physiology laboratory; Faculty of Medicine and Pharmacy of Rabat, Mohammed V University in Rabat, Rabat, Morocco., Allali F; Department of Rheumatology B, El Ayachi Hospital, Ibn Sina University Hospital, Salé, Morocco., Bahiri R; Department of Rheumatology A, El Ayachi Hospital, Ibn Sina University Hospital, Salé, Morocco., Ahid S; Research Team of Pharmacoeconomics and Pharmacoepidemiology, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco.; Euromed Faculty of Pharmacy, Euromed University of Fes (UEMF), Fez, Morocco.
Jazyk: angličtina
Zdroj: International journal of rheumatic diseases [Int J Rheum Dis] 2024 Oct; Vol. 27 (10), pp. e15367.
DOI: 10.1111/1756-185X.15367
Abstrakt: Introduction: The aims of study are to estimate the indirect costs and intangible costs of RA in Morocco and to identify the factors likely to influence these costs among suffering patients.
Methods: In the current study, data were collected by face-to-face interviews using a questionnaire in addition to the patient's files. Indirect costs including productivity losses and formal care, and intangible costs such as the cessation of physical and leisure activities, family care and divorce or remaining single until menopause's age for women due to the disease were reported for 110 RA patients.
Results: The results show that among patients who lost totally or partially their salary, the annual average costs is $2337.73 ± 1649.80 per patient, with a minimum and a maximum of $600 and $9630 respectively. As regards formal care, only 13 patients reported that they paid for care services; the annual average cost was $421.84 ± 261.34 with a minimum of $252 and a maximum of $1200. Statistical analysis revealed significant differences between annual lost salary and gender (p = .04) disease duration (p = .016) and sport/leisure activities cessation (p = .08).
Conclusion: Besides the burden in terms of productivity loss and caregivers' costs, the intangible costs are considerable, especially those related to divorce and spinsterhood. These conclusions may contribute to the understanding of the socio-economic impact of the disease and to the development of strategies for better governance of RA in Morocco.
(© 2024 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.)
Databáze: MEDLINE
Externí odkaz: